XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 1,270,131 $ 4,278,124
Restricted cash (note 3) 5,166 8,253
Short-term investments (note 4) 9,953,042 7,034,569
Accounts receivable - net (note 6) 440,019 537,118
Inventories (note 7) 139,874 180,719
Prepaid expenses and deposits 11,621 15,242
Income tax receivable 10,703 72,371
Total current assets 11,830,556 12,126,396
Property, plant and equipment - net (note 8) 979,617 993,781
Prepaid land lease payments (note 9) 65,540 69,815
Intangible assets - net (note 10) 8,520 9,699
Long-term prepaid expenses (note 13(b)) 24 23
Long-term investments (note 4) 684,285 661,440
Prepayments for acquisition of equipment 6,772 120,912
Deferred tax assets (note 15) 29,790 71,118
Right-of-use assets (notes 11 and 13(b)) 45,525 58,586
Other non-current assets 7,345 2,798
Total assets 13,657,974 14,114,568
Current liabilities    
Short-term bank loans and current portion of long-term bank loans (note 12) 76,089 293
Loan from a non-controlling shareholder (note 13 (a)) 0 4,358
Accounts payable and accrued liabilities (note 14) 973,949 905,923
Income tax payable 41,258 0
Deferred revenue (note 16) 20,127 17,955
Deferred government grants (note 17) 1,586 15,120
Dividend payable (note 19) 29,089 141,993
Lease liability (notes 11 and 13(b)) 5,806 5,993
Total current liabilities 1,147,904 1,091,635
Deferred revenue 200 0
Deferred government grants (note 17) 5,865 4,477
Long-term bank loans (note 12) 177,817 11,513
Deferred tax liability 263,711 241,526
Lease liability (notes 11 and 13(b)) 39,271 52,516
Other non-current liabilities (note 15) 439 240
Total long-term liabilities 487,303 310,272
Total liabilities 1,635,207 1,401,907
Commitments and contingencies (notes 18 and 24)
EQUITY    
Preferred stock (note 19) Authorized 50,000,000 shares at par value of $0.001 each Issued and outstanding: 14,630,813, including 14,630,813 held in trust (2022 - 14,630,813, 14,630,813) 15 15
Common stock (note 19) Authorized: 100,000,000 shares at par value of $0.001 each Issued and outstanding: 99,502,243, including 27,777,341 held in trust (2022 - 99,638,043, 27,777,341 ) 100 100
Additional paid-in capital 541,258 540,582
Accumulated other comprehensive income (loss) (490,055) (383,276)
Statutory surplus reserves (note 21) 1,539,584 1,538,013
Accumulated earnings 7,118,516 7,225,987
Total shareholders' equity 8,709,418 8,921,421
Non-controlling interests 3,313,349 3,791,240
Total equity 12,022,767 12,712,661
Total liabilities and equity $ 13,657,974 $ 14,114,568